Cumberland Partners With Chronicled’s MediLedger Project To Advance Blockchain Supply Chain Networks for Pharma Manufacturers

NASHVILLE, Tenn.–(BUSINESS WIRE)–#mediledger—Cumberland announced today that it has joined forces with Chronicled as a preferred systems integration partner for the San Francisco-based technology company’s MediLedger Project, an initiative that builds blockchain-powered ecosystems and supply chain solutions. Chronicled is helping the pharmaceutical industry to launch a permissioned blockchain network based on open standards and specifications. Cumberland … [Read more…]

Topcon to Attend American Academy of Ophthalmology 2019 Meeting

Meeting Highlights Include New Product Introductions, an OCT Technology Symposium and the Debut of Topcon Healthcare the “Next Generation in Healthcare Insights Through the Eye” OAKLAND, N.J.–(BUSINESS WIRE)–#AAO—Topcon Medical Systems, a leading provider of medical devices and software solutions for the eye care community, is pleased to announce its participation in the 2019 American Academy … [Read more…]

Global Cardiac Pacemakers Market Report, 2019-2025 –

DUBLIN–(BUSINESS WIRE)–The “Cardiac Pacemakers – Market Analysis, Trends, and Forecasts” report has been added to’s offering. Cardiac Pacemakers market worldwide is projected to grow by US$2.4 Billion, driven by a compounded growth of 6.7%. External Pacemaker Devices, one of the segments analyzed and sized in this study, displays the potential to grow at over … [Read more…]

CORRECTING and REPLACING VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#Clinicaltrials–Please note the Hope Biosciences boilerplate has been updated. The corrected release reads: VIRTRIAL AWARDED FDA-APPROVED DECENTRALIZED CLINICAL TRIAL WITH HOPE BIOSCIENCES VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of spinal … [Read more…]

Global Respiratory Diseases 2019 Including: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis –

DUBLIN–(BUSINESS WIRE)–The “Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers” report has been added to’s offering. About this Report This new 366-page report from the author presents detailed analysis of the Respiratory Disease market in the US, Europe … [Read more…]

Mauna Kea Technologies Announces Positive Results on Needle-Based Endomicroscopy for Differentiating and Managing Pancreatic Cystic Lesions

Three recent clinical publications demonstrate that Cellvizio® AQ-Flex™ 19 Confocal Miniprobe significantly improves diagnostic accuracy versus standard of care, positively impacting management of patients with pancreatic cystic lesions PARIS & BOSTON–(BUSINESS WIRE)–Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA,) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced … [Read more…]

City of Hope Is Enrolling Patients in First of Its Kind Clinical Trial for Brain Tumor Patients

The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research, combines City of Hope’s unique CAR T cell therapy with immune checkpoint inhibitors DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma – the trial is the first … [Read more…]

Medgen Inc. Signs Letter of Intent to Acquire Magnifind.Ca

TORONTO–(BUSINESS WIRE)–Medgen, Inc. (OTC: MDIN) has entered into a Letter of Intent to acquire 9430075 Canada Ltd. operating as (“Magnifind”) based in Winnipeg, MB. This acquisition, which is expected to be completed upon Magnifind US GAAP Audit being finished, puts Medgen squarely into the Medical Services related field. We anticipate that the acquisition should … [Read more…]

CURE Media Group Announces Debbie Biddle as the CURE® Magazine Cover Contest Winner

Biddle’s artwork will be featured on the fall seasonal cover of CURE® magazine CRANBURY, N.J.–(BUSINESS WIRE)–#Art–CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research, has announced that after 72 submissions and over 1,800 votes, Debbie Biddle’s piece titled “Whirlwind” is … [Read more…]

Succeed in the Growing Mobility Market with Bioiberica at Supply Side West 2019

The company will present its comprehensive portfolio of science-backed, on-trend nutraceutical ingredients, specifically designed to deliver greater mobility It will also showcase its ability to support supplement, food and beverage manufacturers in meeting growing demand for more holistic joint health products BARCELONA, Spain–(BUSINESS WIRE)–#chondroitinsulfate—Bioiberica, a global life science company committed to the health and wellbeing … [Read more…]